This article reports on a case of biopsy-proven nodular glomerulosclerosis in a patient with progressively worsening renal function, metabolic syndrome, but no evidence of diabetes. The authors conclude that screening patients with the metabolic syndrome—even those without diabetes—for evidence of impaired renal function and treating eventually detected albuminuria could help prevent progressive kidney disease and reduce the associated morbidity and mortality risks.
- Pierre Souraty
- Cynthia C Nast
- Sharon G Adler
